A-Life Medical promotes Connolly to CEO

Jeff Byers | | Health Imaging | Artificial Intelligence
A-Life Medical has promoted Jaye Connolly to the post of CEO, effective immediately. Connolly had been serving as president of the computer-assisted coding company since April, and will continue in that role as well, according to A-Life.

In addition to her role as CEO and president, Connolly will continue as a member of the board of directors for both A-Life Medical and A-Life Hospital, a wholly owned subsidiary of A-Life Medical.

Prior to her current position, Connolly was chief operating officer and chief financial officer at A-Life Medical for more than five years, according to the San Diego-based company.

Jeff Byers

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.